The UK’s Delayed Defence Plan: What’s at Stake?
Why It Matters
The delayed UK defence plan determines future funding for firms like Kinetic, directly influencing revenue stability and investor valuations across the sector.
Key Takeaways
- •Kinetic's revenue flat despite rising defense spending, highlighting underperformance.
- •US operations downsizing and underperforming acquisition strain Kinetic's outlook.
- •UK defence investment plan delayed, crucial for Kinetic's 75% UK revenue.
- •Sector valuation pressures cause share pullbacks despite strong earnings growth.
- •Cohort shows earnings growth, appears undervalued versus larger defence peers.
Summary
The discussion centers on the UK government’s long‑awaited defence investment plan and its ripple effects on domestic contractors, notably Kinetic and Cohort. Analysts note that Kinetic, a former MOD research arm, posted flat revenue while trimming its US operations and wrestling with a poorly performing 2022 acquisition, leaving its outlook uncertain despite an 18% rise in operating profit. Key data points include Kinetic’s heavy reliance on UK contracts—about three‑quarters of revenue and two‑thirds directly from the MOD—and the pending investment plan that could unlock new funding streams. Meanwhile, the broader sector has seen share price volatility: valuations surged after the Russia‑Ukraine war, then softened amid geopolitical jitters and concerns that promised European spend isn’t materialising as quickly as expected. Notable examples cited are Kinetic’s potential sale of its US IT business and Cohort’s recent trading update, which turned a 40% share slump into a perceived bargain given its earnings growth and lower PE multiples compared with giants like BAE Systems. The stakes are clear: investors will gauge the forthcoming plan for commitment levels, especially on projects such as next‑generation fighters and nuclear capabilities. A robust rollout could lift under‑valued players, while continued delays risk further earnings pressure and market underperformance.
Comments
Want to join the conversation?
Loading comments...